ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

IOM To Form Committee To Investigate Duke Genomics Research

October 1, 2010

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999

Institute of Medicine Elects 80 New Members

October 24, 2014

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011